Plus   Neg

Lanxess Slips To Loss In Q4; Sees Operationally Stable In 2020

Specialty chemicals company Lanxess AG (LNXSF.PK) reported that its fourth-quarter net loss was 48 million euros, compared to net income of 99 million euros in the prior year.

EBITDA pre exceptionals was 197 million euros, up from 175 million euros in the previous year.

Quarterly sales declined 2.3 percent to 1.64 billion euros from 1.67 billion euros in the previous year.

The company said its Management and Supervisory Boards will propose a dividend of 0.95 euros per share to the Annual Stockholders' Meeting on May 13, 2020. The dividend is to be increased again.

For the first quarter of 2020, the specialty chemicals company currently anticipates charges of around 20 million euros from the coronavirus epidemic.

Lanxess expects its operating business to remain stable in fiscal 2020. However, the company expects the effects of the coronavirus epidemic to impact the operating result by between 50 million euros and 100 million euros for the year as a whole.

The company expects EBITDA pre exceptionals to be between 900 million euros and 1.0 billion euros for 2020.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
U.S. retailers Best Buy Co. Inc., Abercrombie & Fitch Co., and Dollar Tree Inc. on Tuesday reported results for the third quarter that surpassed analysts' expectations. The upbeat results indicate that retailers have largely recovered from the impact of the coronavirus pandemic just as the holiday season approaches. The companies have also intensified their focused on digital sales. The U.S. Food and Drug Administration approved the first drug to treat primary hyperoxaluria type 1 (PH1), an ultra-rare genetic disorder which causes recurrent kidney stones and loss of kidney function. Alnylam Pharmaceuticals' Oxlumo (lumasiran) in the form of injection lowers urinary oxalate levels in pediatric and adult patients. The U.S. federal government's General Services Administration or GSA has awarded a five-year federal transportation contract, estimated to be worth up to $810 million, to Uber Technologies Inc. and Lyft Inc., according to multiple reports. Under the contract, the ride-hailing companies would provide services to various public agencies and their around 4 million employees across the nation.
Follow RTT